WVU Hospitals — Ruby Memorial Hospital’s Post

The bipartisan leadership of the Congressional Neuroscience Caucus, led by Representatives Earl Blumenauer (D-OR), Morgan Luttrell (R-TX), Bill Pascrell (D-NJ), and Brian Fitzpatrick (R-PA), are circulating a Dear Colleague sign-on letter to the House Appropriations Committee in support of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. This initiative will fund the development of technologies which are critical in unlocking the invisible wounds associated with traumatic brain injury (TBI). At TBI Action Alliance, we strongly support the BRAIN Initiative and are committed to driving TBI research and innovation forward. Take action now by urging your members of Congress to support promising brain research at the link below: https://lnkd.in/g9icurc8 #BRAINInitiative #TBIAction #TBI #TBIActionAlliance #BrainHealth

In our most recent educational webinar, Dr. Thomas PREVOT of the University of Toronto, shared insights into a method developed by his research group to alleviate stress and reactivity in research mice. While numerous studies have highlighted the amiable nature of laboratory rats during interactions with experimenters and caregivers, mice often face the challenge of being perceived as difficult to handle, unpredictable, and resistant to acclimating to human interactions. If you missed this episode, it’s not too late! Learn more and tune into the on-demand recording: https://bit.ly/42U6fKQ

Myasthenia gravis is a hot topic at the moment. At this year’s European Academy of Neurology 2024 Congress, Professor Nils Erik Gilhus from the Universitetet i Bergen (UiB) had the honor of presenting a named lecture at the presidential symposium highlighting the many new treatment opportunities in myasthenia gravis. In this MEDtalk, he briefly outlines the presentation. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dmWquMkt #EAN24 #MyastheniaGravis #Treatment

The recording of our recent #opnMe online seminar, "Applying Optogenetics to Analyze Neuronal Networks in Mental Health", is now available for on-demand viewing. Again, many thanks to our speakers @George Augustine, @Martin Graf (Temasek Life Sciences Laboratory Ltd), and @Liz Tunbridge (Boehringer Ingelheim) for their engaging talks and excellent discussions. Their presentations illuminated the applications of optogenetics in the study of the complex neuronal networks, and the underlying biology in the claustrum and prefrontal cortex of the brain. This research holds the promise to discover novel therapeutic concepts for persons living with mental health conditions. Watch now: https://lnkd.in/es5iUASn

Myasthenia gravis is a hot topic at the moment. At this year’s European Academy of Neurology 2024 Congress, Professor Nils Erik Gilhus from the Universitetet i Bergen (UiB) had the honor of presenting a named lecture at the presidential symposium highlighting the many new treatment opportunities in myasthenia gravis. In this MEDtalk, he briefly outlines the presentation. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dV62Xfaq #EAN24 #MyastheniaGravis #Treatment

This is a milestone paper for tauopathies, in particular the 4R types : progressive supranuclear palsy and corticobasal degeneration

Myasthenia gravis is a hot topic at the moment. At this year’s European Academy of Neurology 2024 Congress, Professor Nils Erik Gilhus from the Universitetet i Bergen (UiB) had the honor of presenting a named lecture at the presidential symposium highlighting the many new treatment opportunities in myasthenia gravis. In this MEDtalk, he briefly outlines the presentation. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dzTEGiny #EAN24 #MyastheniaGravis #Treatment

🌟 Discovering the Signs of Long COVID 🌟 🧠 Did you know that cognitive slowing could be a key indicator of long COVID? 🤔 Recent research suggests that reaction time to visual stimuli holds promise as a cognitive marker for this condition. 🚦 🔬 This groundbreaking finding sheds light on the potential neurological impacts of long COVID, further emphasizing the need for continued research and support for those affected. 💪 😮 It's fascinating how our brains work! Understanding these cognitive changes can help improve diagnosis and treatment strategies, ensuring that individuals with long COVID receive the care they need. 🌈 💡 Let's spread awareness about this critical aspect of long COVID and support those who may be experiencing cognitive slowing. Together, we can help pave the way for better understanding and recovery. 🌟 https://hubs.la/Q02jCWdV0 #LongCOVID #CognitiveSlowing #Neuroscience #SupportAndAwareness #ResearchMatters

I'm please to share my first ever interview about my work as part of the Meet the Authors series for Neuropsychopharmacology. Dr Hayley Thorpe and I discuss antidepressant discontinuation syndrome, my recent paper on 5-HT neurochemistry in published in NPP in April, and ongoing questions we have about the syndrome and its neurological mechanisms. https://lnkd.in/eWYg-uAG

Listen to BAF Research Grant Recipient and Board Member, Vincent M. Tutino, Ph.D. He will share all things brain aneurysm related; exploring topics such as how and why they form, what causes them to grow and rupture, the best treatment options available, and the latest advancements in detecting aneurysms. https://lnkd.in/e68m_DFd